Home > Products > Active Pharmaceutical Ingredient (API)

Sinae Active Pharmaceutical Ingredient (API) fabrica, supplementum, Factory

Jiangsu Run'an Pharmaceutical Co, Ltd., subsidiaria omnino possessa de Jiangsu Chiatai Qingjiang Pharmaceutical Co, Ltd., modernus summus tech pharmaceuticus societas specialis in R&D, productionis et venditio fertilitatis ordinandae medicinae et varietatis APIs. Project constructionem mense Novembri 2018 incepit, LIX mu aream obtegens, cum tota obsidione 160 decies Yuan et tota area aedificium 25000 quadratum metrorum.

Praecipua activum medicamentum pharmaceuticum (API) producta: Hydrochloridem Gemcitabinum, Celecoxib, bromhexinum hydrochloridum, Iguratimod, Apremilast, Citrate Tofactinib, Crisaborole, Urapidil Hydrochloride, Sugammadex Natrium, Garlicin, Dexmedetomidine Hydrochloride, Rocuronium Bromidum, Finerenone, etc. elit mundi genus facti et productorum gignentium opificem per constantem emendationem et innovationem in technologiarum, et occasiones praeclarum negotium praebent sodalibus nostris per orbem terrarum. Munus nostrum ad praestantes operas emptores nobis permisit solidas relationes cum sociis nostris toto orbe includere.

View as  
 
(+) - N. [2- [I (s) - (III-Ethoxy-IV-IV-methoxyphen) -2- (-2--2,3, Dihydro -1,3-IV-YL] Acetamide

(+) - N. [2- [I (s) - (III-Ethoxy-IV-IV-methoxyphen) -2- (-2--2,3, Dihydro -1,3-IV-YL] Acetamide

Seres Product Name: AESTA
Sinica alias: (s) -2- [1- (III-Ethoxy-IV-IV-methoxyphenyl) -2, methaneulfonylethyl] -4, acetylaminoisoisoiso, 1,3 -Diketone
Anglicus Product Name: Apremlast
CAS # 608141-41-9
Molecular Formula: C22H24N2O7s
Molecular pondus: 460,5
(+)-N-[2-[1(S)-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]acetamide is for psoriatic arthritis drug, psoriasis and psoriatic arthritis drug.

Lege plusMitte Inquisitionem
Apremilast API

Apremilast API

Seres Product Name: AESTA
Sinica alias: (s) -2- [1- (III-Ethoxy-IV-IV-methoxyphenyl) -2, methaneulfonylethyl] -4, acetylaminoisoisoiso, 1,3 -Diketone
Anglicus Product Name: Apremilast API
CAS # 608141-41-9
Molecular Formula: C22H24N2O7s
Molecular pondus: 460,5

Lege plusMitte Inquisitionem
Arthritis iguratimod

Arthritis iguratimod

Seres Product Name: Ellamod
Seres alias: N [3 (Carboxamido) -4-Oxo-VI-phenoxy-4h-I-Benzopyran-VII-YL] Methanesulfonamide
Anglicus Product Name: Arthritis Iguratimod
CAS # 123663-49-0
Molecular formula: c17h14n2o6s
Molecular pondus: 374,3679
Specie et proprietates alba pulveris
Domesticis Registration Number API: Y20190021542

Lege plusMitte Inquisitionem
Rheumatic arthritis iguratimod

Rheumatic arthritis iguratimod

Seres Product Name: Ellamod
Seres alias: N [3 (Carboxamido) -4-Oxo-VI-phenoxy-4h-I-Benzopyran-VII-YL] Methanesulfonamide
Anglicus Product Name: Rheumatic arthritis Iguratimod
CAS # 123663-49-0
Molecular formula: c17h14n2o6s
Molecular pondus: 374,3679
Specie et proprietates alba pulveris
Domesticis Registration Number API: Y20190021542

Lege plusMitte Inquisitionem
Cas no.123663-49-0

Cas no.123663-49-0

Seres Product Name: Ellamod
Seres alias: N [3 (Carboxamido) -4-Oxo-VI-phenoxy-4h-I-Benzopyran-VII-YL] Methanesulfonamide
Latina Product Name: iguratimod
Cas no.123663-49-0
Molecular formula: c17h14n2o6s
Molecular pondus: 374,3679
Specie et proprietates alba pulveris
Domesticis Registration Number API: Y20190021542

Lege plusMitte Inquisitionem
CAS 123663-49-0

CAS 123663-49-0

Seres Product Name: Ellamod
Seres alias: N [3 (Carboxamido) -4-Oxo-VI-phenoxy-4h-I-Benzopyran-VII-YL] Methanesulfonamide
Latina Product Name: iguratimod
CAS 123663-49-0
Molecular formula: c17h14n2o6s
Molecular pondus: 374,3679
Specie et proprietates alba pulveris
Domesticis Registration Number API: Y20190021542

Lege plusMitte Inquisitionem
Quiescere potes ex officina nostra emere Active Pharmaceutical Ingredient (API) in Sinis. Pharmaceutical Run'an professionalis Sinarum Active Pharmaceutical Ingredient (API) fabrica et supplementum, qualitas products alta praebere possumus. Grata res emendas ex officina nostra.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept